Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

2 Firms Drive $13.1B Heart Disease Treatment Developer Deal(Law360)

main

10_05 2 Firms Drive Heart Disease

2 Firms Drive $13.1B Heart Disease Treatment Developer Deal <em>(Law360)</em>

2 Firms Drive $13.1B Heart Disease Treatment Developer Deal(Law360)

Related Content

FTC Issues Final Rule Prohibiting Most Post-Employment Non-Compete Agreements

At the Intersection of ‘S’ and ‘G’ of ESG: London Leading the Way on Board Diversity — An Update on Latest FTSE Women Leaders Review and Parker Review Reports

New SEC Climate Rules Stayed by Fifth Circuit – For Now

The Coming Storm: Preparing for The SEC's Final Climate-Related Disclosure Rules

Delaware Court of Chancery Rescinds Elon Musk’s $55.8 Billion Compensation Package in Cautionary Tale About Director Independence and Executive Compensation

SEC Adopts New Rules Applicable to SPACs, Shell Companies and Projections

Cybersecurity — Cracking the Code on Upcoming Disclosures

Careful Review of Litigation Disclosure in Periodic Reports and Registrations Statement Required Following U.S. District Court’s Decision

Board Composition Key to IPO Readiness (Sifted)

Once Again, Goodwin Is The Top Firm for Global M&A

M&A Partner Joins Practice at Goodwin In NY (Law360)

Goodwin Recruits Gill to M&A Practice, Life Sciences Group in NY (Bloomberg Law)

Former SEC Lawyer Joins Goodwin (IFLR)

Goodwin Welcomes SEC Alum Lynn to Lead Public Companies Team (Bloomberg Law)

Leading Capital Markets Partner David Lynn Joins Goodwin to Chair Public Company Advisory Practice

Goodwin Hires Ex-SEC Lawyer (Law360)

Life Sciences

Technology

Healthcare

Public Company Advisory Practice

Mergers & Acquisitions

Employment

ERISA Litigation

Complex Litigation & Dispute Resolution

Opinions & Counseling

Tax

Litigation